Cancer Diagnostics Market, By Product Type (Consumables, Instruments, and Software & Bioinformatics Solutions), By Technology, By Test Type, By Application, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4036
|
Published Date
June 2025
|
Pages
396
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Cancer Diagnostics Market size was valued at US$ 108,543.12 Million in 2024, expanding at a CAGR of 6.5% from 2025 to 2032.
The cancer diagnostics market is centered on the development and deployment of advanced technologies and tests designed to detect cancer at its earliest stages, enabling timely and more effective treatment. Rising awareness of the importance of cancer screening, the increasing global incidence of cancer, and significant advancements in molecular diagnostics and imaging technologies are driving market growth. According to the World Health Organization, nearly one in six deaths worldwide is attributed to cancer, underscoring the critical need for improved diagnostic solutions.
Despite this demand, the market faces challenges such as the high costs associated with advanced diagnostic procedures, limited accessibility in developing regions, and regulatory hurdles. However, emerging opportunities are found in the integration of artificial intelligence (AI) and liquid biopsy technologies, which offer non-invasive and highly accurate detection methods. Furthermore, expanding government initiatives and increased funding to support early cancer detection programs create a favorable environment for innovation and sustained market growth.
Cancer Diagnostics Market- Market Dynamics
Rising Cancer Prevalence and Technological Advances to Accelerate Adoption of Diagnostics
Rising cancer prevalence and technological advancements are driving the increased adoption of improved diagnostic tools worldwide. According to the World Health Organization, cancer is responsible for nearly 10 million deaths annually, making early and accurate detection essential for effective treatment. Innovations such as liquid biopsies and AI-powered imaging are revolutionizing traditional diagnostic approaches by providing faster, less invasive options.
Programs funded by the U.S. National Cancer Institute have shown that early-stage cancer detection can boost survival rates by up to 90% for certain cancers, including breast and colorectal cancer. Additionally, government initiatives in countries like Germany and Japan are actively promoting screening programs to support early diagnosis, particularly in aging populations. Globally, a 2024 OECD report reveals that over 75% of member countries have implemented national cancer control plans emphasizing early detection and improved diagnostics, supported by increased public funding and policy frameworks. These efforts underscore the growing focus on leveraging advanced technologies to improve patient outcomes and reduce the global cancer burden.
Cancer Diagnostics Market- Key Insights
- According to our research analyst, the global cancer diagnostics market is projected to grow at a compound annual growth rate (CAGR) of approximately 6.5% between 2025 and 2032.
- In 2024, the instruments segment is expected to hold the largest market share based on product type.
- In terms of technology, in vitro diagnostic (IVD) testing is anticipated to be the leading technology segment in 2024.
- Diagnostic tests are predicted to dominate the market based on test type in 2024.
- Breast cancer represents the largest application segment in 2024.
- Hospitals and cancer centers are expected to be the primary end users in 2024.
- Geographically, North America is projected to generate the highest revenue in 2024.
Cancer Diagnostics Market- Segmentation Analysis:
The Global Cancer Diagnostics Market is segmented on the basis of Product Type, Technology, Test Type, Application, End User, and Region.
The market is segmented into three primary product types: Consumables, Instruments, and Software & Bioinformatics Solutions. Instruments hold a dominant position, driven by advancements in pathology-based devices such as Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS) instruments that lead innovation in molecular diagnostics. Imaging systems, including MRI and CT scanners, are critical for providing detailed anatomical and functional scans that support accurate diagnosis. Consumables such as antibodies, reagents, and assay kits are essential for conducting reliable laboratory tests, while software and bioinformatics solutions play an increasingly vital role in data analysis, interpretation, and integration of complex diagnostic information. According to the U.S. Food and Drug Administration (FDA), the market for molecular diagnostic instruments and reagents saw an annual growth rate exceeding 12% in 2023, fueled by heightened demand for precision diagnostics and personalized medicine.
Based on technology, the market is categorized into In Vitro Diagnostic (IVD) Testing, Imaging, and Biopsy Techniques. IVD testing leads the sector, with PCR and next-generation sequencing enabling detailed molecular insights critical for early disease detection and monitoring. Imaging technologies such as MRI and CT provide high-resolution tumor visualization, essential for treatment planning and disease staging. Biopsy techniques complement these approaches by offering precise tissue sampling and histopathological analysis, which are key for accurate diagnosis and personalized treatment strategies. Data from the National Cancer Institute (NCI) highlights that federal funding for integrated cancer diagnostics, combining IVD, imaging, and biopsy technologies, has increased by 20% over the past five years, underscoring the government’s commitment to advancing comprehensive cancer detection and improving patient outcomes.
Cancer Diagnostics Market- Competitive Landscape:
The competitive landscape of the cancer diagnostics market is characterized by strong collaboration among established pharmaceutical and biotechnology companies, diagnostic tool manufacturers, and innovative startups. Key players are investing heavily in research and development to advance cutting-edge technologies such as liquid biopsies, next-generation sequencing, and AI-powered imaging platforms. Partnerships with hospitals and research institutions are common, facilitating faster clinical validation and adoption of new diagnostic methods. Public-private collaborations also play a vital role in driving innovation and securing regulatory approvals. Many companies are focusing on personalized diagnostic solutions tailored to specific cancer types, enhancing detection accuracy and improving treatment outcomes. Additionally, open-source data initiatives and academic research contribute to rapid advancements, enabling smaller players to enter the market with niche technologies. The competitive environment is thus defined by continuous innovation, strategic alliances, and a strong commitment to improving early detection to address growing global healthcare demands.
Recent Developments:
- May 2025: Metropolis Healthcare launched TruHealth Cancer Screen 360 in India, offering gender-specific and hereditary risk assessments. This comprehensive screening panel aims to improve early cancer detection, affordability, and accessibility, strengthening preventive oncology in both urban and rural areas.
- December 2024: Strand Life Sciences, backed by Reliance, introduced CancerSpot, a non-invasive blood test utilizing advanced methylation profiling to detect multiple cancers at early stages. Designed for diverse populations, CancerSpot seeks to make proactive cancer screening accessible and effective across India and globally.
- December 2024: Apollo Cancer Centre launched India’s first LungLife Screening Programme, targeting early lung cancer detection. This program employs advanced low-dose CT scans to improve survival rates and treatment outcomes by diagnosing lung cancer at earlier, more treatable stages.
- September 2024: Strand Life Sciences unveiled the Somatic Advantage 74 Liquid Biopsy (SA74 LB) Test, a minimally invasive blood test analyzing 74 cancer-related genes. This test enables precise and timely cancer diagnosis and treatment guidance, improving patient outcomes.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CANCER DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- Agilent Technologies
- Biocept, Inc.
- BioMérieux
- Exact Sciences
- Foundation Medicine (Roche)
- Guardant Health
- Hologic, Inc.
- Illumina, Inc.
- Invitae Corporation
- Myriad Genetics
- Natera, Inc.
- Qiagen
- Roche Diagnostics
- Sophia Genetics
- Thermo Fisher Scientific
- Others
GLOBAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Consumables
- Antibodies
- Kits & Reagents
- Probes
- Other
- Instruments
- Pathology-based Instruments
- Slide Staining Systems
- Tissue Processing Systems
- Cell Processors
- PCR Instruments
- NGS Instruments
- Microarrays
- Other
- Imaging Instruments
- CT Systems
- Ultrasound
- MRI Systems
- Mammography Systems
- Nuclear Imaging Systems
- Biopsy Instruments
- Pathology-based Instruments
- Software & Bioinformatics Solutions
GLOBAL CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- IVD Testing
- Polymerase Chain Reaction (PCR)
- In Situ Hybridization (ISH)
- Immunohistochemistry
- Next-generation Sequencing
- Microarrays
- Flow Cytometry
- Immunoassays
- Other
- Imaging
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- Positron Emission Tomography (PET)
- Mammography
- Ultrasound
- Biopsy Technique
GLOBAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032
- Screening Tests
- Diagnostic Tests
- Prognostic Tests
- Predictive Tests
- Monitoring Tests
- Biopsy
- Fine-needle Aspiration
- Core Biopsy
- Surgical Biopsy
- Skin Biopsy /Punch Biopsy
- Others
GLOBAL CANCER DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Breast Cancer
- Colorectal Cancer
- Cervical Cancer
- Lung Cancer
- Prostate Cancer
- Skin Cancer
- Blood Cancer
- Kidney Cancer
- Liver Cancer
- Pancreatic Cancer
- Ovarian Cancer
- Others
GLOBAL CANCER DIAGNOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals & Cancer Centers
- Diagnostic Laboratories
- Research Institutes
- Pharmaceutical & Biotech Companies
GLOBAL CANCER DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Cancer Diagnostics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Cancer Diagnostics Market Snippet by Product Type
2.1.2. Cancer Diagnostics Market Snippet by Technology
2.1.3. Cancer Diagnostics Market Snippet by Test Type
2.1.4. Cancer Diagnostics Market Snippet by Application
2.1.5. Cancer Diagnostics Market Snippet by End User
2.1.6. Cancer Diagnostics Market Snippet by Country
2.1.7. Cancer Diagnostics Market Snippet by Region
2.2. Competitive Insights
3. Cancer Diagnostics Key Market Trends
3.1. Cancer Diagnostics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Cancer Diagnostics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Cancer Diagnostics Market Opportunities
3.4. Cancer Diagnostics Market Future Trends
4. Cancer Diagnostics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Cancer Diagnostics Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Cancer Diagnostics Market Landscape
6.1. Cancer Diagnostics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Cancer Diagnostics Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
7.1.2. Consumables
7.1.2.1. Antibodies
7.1.2.2. Kits & Reagents
7.1.2.3. Probes
7.1.2.4. Other
7.1.3. Instruments
7.1.3.1. Pathology-based Instruments
7.1.3.1.1. Slide Staining Systems
7.1.3.1.2. Tissue Processing Systems
7.1.3.1.3. Cell Processors
7.1.3.1.4. PCR Instruments
7.1.3.1.5. NGS Instruments
7.1.3.1.6. Microarrays
7.1.3.1.7. Other
7.1.3.2. Imaging Instruments
7.1.3.2.1. CT Systems
7.1.3.2.2. Ultrasound
7.1.3.2.3. MRI Systems
7.1.3.2.4. Mammography Systems
7.1.3.2.5. Nuclear Imaging Systems
7.1.3.3. Biopsy Instruments
7.1.4. Software & Bioinformatics Solutions
8. Cancer Diagnostics Market – By Technology
8.1. Overview
8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
8.1.2. IVD Testing
8.1.2.1. Polymerase Chain Reaction (PCR)
8.1.2.2. In Situ Hybridization (ISH)
8.1.2.3. Immunohistochemistry
8.1.2.4. Next-generation Sequencing
8.1.2.5. Microarrays
8.1.2.6. Flow Cytometry
8.1.2.7. Immunoassays
8.1.2.8. Other
8.1.3. Imaging
8.1.3.1. Magnetic Resonance Imaging (MRI)
8.1.3.2. Computed Tomography (CT)
8.1.3.3. Positron Emission Tomography (PET)
8.1.3.4. Mammography
8.1.3.5. Ultrasound
8.1.4. Biopsy Technique
9. Cancer Diagnostics Market – By Test Type
9.1. Overview
9.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
9.1.2. Screening Tests
9.1.3. Diagnostic Tests
9.1.4. Prognostic Tests
9.1.5. Predictive Tests
9.1.6. Monitoring Tests
9.1.7. Biopsy
9.1.7.1. Fine-needle Aspiration
9.1.7.2. Core Biopsy
9.1.7.3. Surgical Biopsy
9.1.7.4. Skin Biopsy /Punch Biopsy
9.1.7.5. Others
10. Cancer Diagnostics Market – By Application
10.1. Overview
10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
10.1.2. Breast Cancer
10.1.3. Colorectal Cancer
10.1.4. Cervical Cancer
10.1.5. Lung Cancer
10.1.6. Prostate Cancer
10.1.7. Skin Cancer
10.1.8. Blood Cancer
10.1.9. Kidney Cancer
10.1.10. Liver Cancer
10.1.11. Pancreatic Cancer
10.1.12. Ovarian Cancer
10.1.13. Others
11. Cancer Diagnostics Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
11.1.2. Hospitals & Cancer Centers
11.1.3. Diagnostic Laboratories
11.1.4. Research Institutes
11.1.5. Pharmaceutical & Biotech Companies
12. Cancer Diagnostics Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Cancer Diagnostics Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Cancer Diagnostics Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Cancer Diagnostics Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Cancer Diagnostics Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Cancer Diagnostics Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Cancer Diagnostics Industry
13.1. Competitive Dashboard
13.1.1. Competitive Benchmarking
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Abbott Laboratories
13.2.2. Agilent Technologies
13.2.3. Biocept, Inc.
13.2.4. BioMérieux
13.2.5. Exact Sciences
13.2.6. Foundation Medicine (Roche)
13.2.7. Guardant Health
13.2.8. Hologic, Inc.
13.2.9. Illumina, Inc.
13.2.10. Invitae Corporation
13.2.11. Myriad Genetics
13.2.12. Natera, Inc.
13.2.13. Qiagen
13.2.14. Roche Diagnostics
13.2.15. Sophia Genetics
13.2.16. Thermo Fisher Scientific
13.2.17. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
